Biomark Capital
Venture capitalGreenwich · Series A–Late Stage · 4 people tracked
Investment thesis
Biomark Capital invests in early through late-stage life science companies focused on diagnostics, therapeutics, medical devices, and digital health. The firm provides funding and operational support to its portfolio companies.
Team · 4 people
from public directoriesFrequently asked questions
- What stage does Biomark Capital invest at?
- Biomark Capital invests at the Series A, Series B, Series C, Late Stage stages.
- What is Biomark Capital's typical check size?
- Biomark Capital typically writes checks of $5M – $10M.
- What sectors does Biomark Capital focus on?
- Biomark Capital focuses on Biotech, Enterprise Software, Healthtech, Medical Devices.
- Where is Biomark Capital located?
- Biomark Capital is headquartered in Greenwich, US.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.